Hikma Pharmaceutical | HIK - Assets

Stock Price
1,632.00
Daily Change
78.00 5.02%
Monthly
6.88%
Yearly
-28.48%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $5.55B in Assets for its fiscal semester ending in June of 2025.





Assets Change Date
Almirall EUR 2.31B 88.74M Jun/2025
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Autolus Therapeutics Ltd USD 661.95M 59.03M Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Galapagos EUR 3.51B 306.31M Sep/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
GRIFOLS EUR 19.85B 86.61M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 50.93B 3.58B Sep/2025
Orion EUR 1.75B 102.1M Sep/2025
Recordati EUR 5.3B 122.58M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 17.35B 1.72B Dec/2024